Dose-reduced first cycle of chemotherapy for prevention of life-threatening acute complications in nonseminomatous germ cell tumor patients with ultra high tumor markers and/or poor performance status. [electronic resource]
Producer: 20180806Description: 1817-1823 p. digitalISSN:- 1432-1335
- Adolescent
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- metabolism
- Cisplatin -- administration & dosage
- Etoposide -- administration & dosage
- Humans
- Male
- Neoplasms, Germ Cell and Embryonal -- drug therapy
- Prognosis
- Retrospective Studies
- Testicular Neoplasms -- drug therapy
- alpha-Fetoproteins -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.